A growing number of older Americans are dropping their weight-loss medications in large numbers.
Seventy-five-year-old Mary Bucklew had tried numerous diets and exercise routines, but nothing seemed to work for her, until a nurse practitioner suggested she try Ozempic. The diabetes medication was initially only covered by Medicare for Type 2 diabetics, but when Bucklew's insurance plan included it as part of her Medicare Advantage package, the results were dramatic. In just six months, she lost 25 pounds and noticed significant improvements in energy levels and overall health.
However, with coverage eventually being denied due to a policy change by her insurer, Bucklew is now among thousands of older adults who have stopped taking weight loss medications like Ozempic after initial success.
Research shows that older Americans represent a prime target for these medications, as obesity rates are high in this age group and diabetes prevalence increases with age. However, side effects such as nausea, bloating, diarrhea, and muscle loss can lead to discontinuation.
The high rate of medication dropout may also be due to shortages and concerns over cost. Medicare coverage limits out-of-pocket payments for prescription drugs, but the Biden administration recently capped these costs at $2,100 per year for some medications, including Ozempic.
Some doctors believe that covering weight loss medications like Ozempic should be made available to all patients, regardless of age or health status.
Seventy-five-year-old Mary Bucklew had tried numerous diets and exercise routines, but nothing seemed to work for her, until a nurse practitioner suggested she try Ozempic. The diabetes medication was initially only covered by Medicare for Type 2 diabetics, but when Bucklew's insurance plan included it as part of her Medicare Advantage package, the results were dramatic. In just six months, she lost 25 pounds and noticed significant improvements in energy levels and overall health.
However, with coverage eventually being denied due to a policy change by her insurer, Bucklew is now among thousands of older adults who have stopped taking weight loss medications like Ozempic after initial success.
Research shows that older Americans represent a prime target for these medications, as obesity rates are high in this age group and diabetes prevalence increases with age. However, side effects such as nausea, bloating, diarrhea, and muscle loss can lead to discontinuation.
The high rate of medication dropout may also be due to shortages and concerns over cost. Medicare coverage limits out-of-pocket payments for prescription drugs, but the Biden administration recently capped these costs at $2,100 per year for some medications, including Ozempic.
Some doctors believe that covering weight loss medications like Ozempic should be made available to all patients, regardless of age or health status.